Regulatory variants of FOXG1 in the context of its topological domain organisation

Author(s):Show less -

Mehrjouy, Mana M. ^[1] ; Fonseca, Ana Carolina S. ^[2] ; Ehmke, Nadja ^{[3, 4]} ; Paskulin, Giorgio ^[5] ; Novelli, Antonio ^[6] ; Benedicenti, Francesco ^[7] ; Mencarelli, Maria Antonietta ^[8] ; Renieri, Alessandra ^[8] ; Busa, Tiffany ^[9] ; Missirian, Chantal ^[9] ; Hansen, Claus ^[1] ; Abe, Kikue Terada ^[10] ; Speck-Martins, Carlos Eduardo ^[10] ; Vianna-Morgante, Angela M. ^[2] ; Bak, Mads ^[1] ; Tommerup, Niels ^[1]

Affiliation

^[1] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Copenhagen - Denmark

^[2] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo - Brazil

^[3] Charite Univ Med Berlin, Inst Med Genet & Humangenet, Berlin - Germany

^[4] BIH, Berlin - Germany

^[5] GENEX Inst Exames Genet Ltda, Porto Alegre, RS - Brazil

^[6] Bambino Gesu Pediat Hosp, IRCCS, Med Genet Lab, Rome - Italy

^[7] Reg Hosp Bolzano, Dept Paediat, Genet Counselling Serv, Bolzano - Italy

^[8] Azienda Osped Univ Senese, Med Genet Unit, Siena - Italy

^[9] Hop Timone Enfants, Dept Genet, Marseille - France

^[10] Rede Sarah Hosp Reabilitacao, Brasilia, DF - Brazil

• Document type: Journal article
• Source: European Journal of Human Genetics; v. 26, n. 2, p. 186-196, FEB 2018.
• Web of Science Citations: 4

Abstract

FOXG1 syndrome is caused by FOXG1 intragenic point mutations, or by long-range position effects (LRPE) of intergenic structural variants. However, the size of the FOXG1 regulatory landscape is uncertain, because the associated topologically associating domain (TAD) in fibroblasts is split into two domains in embryonic stem cells (hESC). Indeed, it has been suggested that the pathogenetic mechanism of deletions that remove the stem-cell-specific TAD boundary may be enhancer adoption due to ectopic activity of enhancer(s) located in the distal hESC-TAD. Herein we map three de novo translocation breakpoints to the proximal regulatory domain of FOXG1. The classical FOXG1 syndrome in these and in other translocation patients, and in a patient with an intergenic deletion that removes the hESC-specific TAD boundary, do not support the hypothesised enhancer adoption as a main contributor to the FOXG1 syndrome. Also, virtual 4 C and HiC-interaction data suggest that the hESC-specific TAD boundary may not be critical for FOXG1 regulation in a majority of human cells and tissues, including brain tissues and a neuronal progenitor cell line. Our data support the importance of a critical regulatory region (SRO) proximal to the hESC-specific TAD boundary. We further narrow this critical region by a deletion distal to the hESC-specific boundary, associated with a milder clinical phenotype. The distance from FOXG1 to the SRO (> 500 kb) highlight a limitation of ENCODE DNase hypersensitivity data for functional prediction of LRPE. Moreover, the SRO has little overlap with a cluster of frequently associating regions (FIREs) located in the proximal hESC-TAD. (AU)

• FAPESP's process: 11/14293-4 - Characterization of apparently balanced chromosomal rearrangements and of its association to the phenotype of carriers
• Grantee: Ana Carolina dos Santos Fonseca
• Support Opportunities: Scholarships in Brazil - Doctorate
• FAPESP's process: 13/08028-1 - CEGH-CEL - Human Genome and Stem Cell Research Center
• Grantee: Mayana Zatz
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
• FAPESP's process: 13/01146-9 - Characterization of apparently balanced chromosomal rearrangements and its association with the phenotype of carriers: breakpoint mapping by mate pair sequencing
• Grantee: Ana Carolina dos Santos Fonseca
• Support Opportunities: Scholarships abroad - Research Internship - Doctorate